CT colonography detects cancer among seniors with no colorectal cancer symptoms.
Computed tomography colonography (CTC) detects more cancer among seniors without symptoms compared with younger adults, according to a study published in the American Journal of Roentgenology.
Researchers from the United States and Italy performed a systematic review of CTC studies to assess the rate of lesion detection among adults aged 65 years and older. They reviewed studies published between January 1994 and August 2017 containing data on senior-age adults and primary endpoint or the CTC-positive rate for large colorectal polyps (10 mm or larger) and masses. Secondary endpoints included lesions 6 mm or larger, proven advanced neoplasia, and colorectal cancer (CRC).
The researchers included 34 studies with 41,680 (18,798 senior-age) subjects. They found pooled CTC-positive rates among senior-age patients using the 10-mm size threshold were significantly lower in cohorts of patients with no symptoms (8.2 percent) compared with cohorts of patients with positive fecal occult blood tests (32.8 percent) and other symptoms of CRC (14 percent). “However, a uniformly high positive predictive value for advanced neoplasia at colonoscopy was seen for all senior-age cohorts using a 10-mm threshold (84.3 percent) where such data were available,” they wrote. The CTC sensitivity for CRC was 93 percent in senior-age patients compared with 92 percent in younger patients. Overall, the CTC detection rates were higher in senior-age adults compared with younger adults.
While CTC-positive rates were higher among older patients and those with CRC symptoms, on average, one in every 12 senior-age adults without symptoms of CRC who underwent screening would be referred to colonoscopy using the 10-mm threshold, with a high yield for advanced neoplasia and high sensitivity for cancer detection, the researchers concluded.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.